Chemokine Receptors in MRI Contrast-Induced Organ Fibrosis

MRI 对比诱发的器官纤维化中的趋化因子受体

• 批准号: 9297293
• 负责人: BRENT WAGNER
• 金额: $ 13.93万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-18 至 2018-03-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9297293
• 关键词: Acute; Address; Affect; Alkaline Phosphatase; Animal Model; Animals; Area; Biodistribution; Bone Marrow; Bone Marrow Cells; CD34 gene; Cells; Cellularity; Chemicals; Chemotactic Factors; Chronic; Contrast Media; Data; Deposition; Dermal; Dermis; Disease; Dose; Engraftment; Exposure to; Extracellular Matrix; Femur; Fibrosis; Flow Cytometry; Gadolinium; Generations; Genetic; Goals; Heart; Human; Impairment; Infiltration; Kidney; Kidney Failure; Lead; Lesion; Leukocytes; Liver; Lung; Magnetic Resonance Imaging; Marrow; Measures; Mediating; Mediator of activation protein; Mesenchymal; Modeling; Molecular; Monocyte Chemoattractant Protein-1; Mus; Muscle; Nephrectomy; Organ; Outcome; PTPRC gene; Pathology; Patients; Pattern; Play; Process; Procollagen; Randomized; Rattus; Recruitment Activity; Renal function; Resistance; Risk Factors; Rodent; Role; Site; Skin; Spleen; Stimulus; Testing; Tissues; Transgenic Organisms; Transplantation; Wild Type Mouse; base; bone cell; chemokine; chemokine receptor; contrast imaging; design; experimental study; precursor cell; progenitor; public health relevance

DESCRIPTION (provided by applicant): Exposure to gadolinium-based magnetic resonance imaging (MRI) contrast is a major risk factor in the acquisition of nephrogenic systemic fibrosis (NSF), a severely debilitating disease first recognized in patients with acute or chronic renal impairment. MRI contrast agents heretofore were considered safe in these patients and thus indiscriminately used. Gadolinium-based contrast agents remain a mainstay for MR imaging and alternatives are still lacking. The overall objective of this proposal is to identify candidate mechanisms that trigger the aberrant pattern of fibrosis after exposure to gadolinium-based MRI contrast in the setting of renal insufficiency. The central hypothesis is that in the setting of real insufficiency, MRI contrast exposure triggers a pro-fibrotic state in target organs, such as the skin. Subsequent generation of specific chemokines activate and recruit bone marrow-derived and circulating mesenchymal precursor cells, or fibrocytes, to the affected areas. These cells compound the fibrotic process by synthesizing and reducing the generation of extracellular matrix and inducing the proliferation of resident cells. Experiments will address the following Specific Aims. 1a, Determine the mechanism by which gadolinium-based contrast induces NSF. 1b, Demonstrate that gadolinium-based contrast induces an increase in circulating fibrocytes. 2a, Identify the chemokines and receptors responsible for recruitment of bone marrow-derived cells to specific tissues. Resistance to NSF will be examined in animals with a genetic deficiency CCR2. 2b, Test the hypothesis that biodistribution of gadolinium differs between normal renal function and renal insufficiency in mice and rats. The chemical mediators that lead to the recruitment of circulating cells to NSF lesions are not well-explored. The findings will lea to a better understanding of how systemic fibrosis occurs and why certain organs are targeted. These will be applicable to NSF and other fibrocyte-mediated ailments.

描述（由申请人提供）：暴露于钆基磁共振成像（MRI）造影剂是发生肾源性系统性纤维化（NSF）的主要风险因素，NSF是一种在急性或慢性肾损害患者中首次发现的严重衰弱性疾病。迄今为止，MRI造影剂在这些患者中被认为是安全的，因此被不加区别地使用。基于钆的造影剂仍然是MR成像的主流，并且仍然缺乏替代品。 本提案的总体目标是确定在肾功能不全的情况下暴露于基于钆的MRI造影剂后触发异常纤维化模式的候选机制。中心假设是，在真实的功能不全的情况下，MRI造影剂暴露触发靶器官（如皮肤）的促纤维化状态。随后产生的特异性趋化因子激活并募集骨髓来源的和循环的间充质前体细胞或纤维细胞到受影响的区域。这些细胞通过合成和减少细胞外基质的产生并诱导驻留细胞的增殖来复合纤维化过程。实验将针对以下具体目标。1a，确定钆基造影剂诱导NSF的机制。1b，证明钆基造影剂诱导循环纤维细胞增加。2a，鉴定负责将骨髓来源的细胞募集到特定组织的趋化因子和受体。将在CCR2遗传缺陷动物中检查对NSF的抗性。2b，检验钆的生物分布在小鼠和大鼠的正常肾功能和肾功能不全之间不同的假设。 导致循环细胞募集至NSF病变的化学介质尚未充分探索。这一发现将使莱亚更好地理解系统性纤维化是如何发生的，以及为什么某些器官是靶向的。这些将适用于NSF和其他纤维细胞介导的疾病。